Suit Claims Illumina's Sequencer Infringes DNA Amplification Patent

The suit claims that Illumina's Genome Analyzer and related products and services infringe a patent originally issued to Genelabs and now held by a firm called LadaTech.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.